Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
PLoS neglected tropical diseases（2023）
摘要
ClinicalTrials.gov identified: NCT03342898.
更多查看译文
关键词
yellow fever,vaccine
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要